Aia Group LTD Viatris Inc Transaction History

Aia Group LTD

$4.23 Billion
Q2 2025

A detailed history of Aia Group LTD transactions in Viatris Inc stock. As of the latest transaction made, Aia Group LTD holds 211,455 shares of VTRS stock, worth $2.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

211,455

Previous 240,610 12.12%

Holding current value

$2.2 Million

Previous $2.1 Million 9.88%

% of portfolio

0.04%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$7.26 - $9.12 $211,665 - $265,893	-29,155 Reduced 12.12%	211,455 $1.89 Million
Q1 2025 May 12, 2025	BUY	$8.68 - $12.42 $581,950 - $832,698	67,045 Added 38.63%	240,610 $2.1 Million
Q4 2024 Feb 12, 2025	SELL	$11.32 - $13.37 $97,985 - $115,730	-8,656 Reduced 4.75%	173,565 $2.16 Million
Q3 2024 Oct 31, 2024	SELL	$10.32 - $12.13 $232,344 - $273,094	-22,514 Reduced 11.0%	182,221 $2.12 Million
Q2 2024 Jul 31, 2024	BUY	$10.05 - $12.02 $287,882 - $344,312	28,645 Added 16.27%	204,735 $2.18 Million
Q1 2024 May 06, 2024	BUY	$11.27 - $13.53 $1.98 Million - $2.38 Million	176,090 New	176,090 $2.1 Million
Q1 2023 Apr 28, 2023	BUY	$9.2 - $12.26 $645,840 - $860,652	70,200 Added 709.81%	80,090 $770,000
Q4 2022 Jan 31, 2023	SELL	$8.72 - $11.56 $42,911 - $56,886	-4,921 Reduced 33.23%	9,890 $110,000
Q3 2022 Nov 04, 2022	SELL	$8.48 - $11.13 $48,140 - $63,185	-5,677 Reduced 27.71%	14,811 $126,000
Q2 2022 Aug 11, 2022	BUY	$9.95 - $12.27 $41,202 - $50,810	4,141 Added 25.33%	20,488 $215,000
Q1 2022 May 06, 2022	BUY	$9.81 - $15.4 $50,237 - $78,863	5,121 Added 45.62%	16,347 $178,000
Q3 2021 Nov 05, 2021	BUY	$13.25 - $15.13 $148,744 - $169,849	11,226 New	11,226 $152,000

Others Institutions Holding VTRS

# of Institutions

1,140

Shares Held

973M

Call Options Held

7.62M

Put Options Held

2.97M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account